Third, preliminary evidence suggests that the MAFLD definition might better capture patients who might benefit from an evaluation of genetic risks for fatty liver, as PNPLA3 rs738409 seems to be associated with MAFLD [48], but also with the development of kidney abnormalities [23,49]. The gene discussed is PNPLA3; the disease is Abnormality of the kidney.